Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fredj

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|June 1, 1992
Intratumor treatment of C3H mouse mammary carcinoma with 5-fluorouracil adsorbed on activated charcoal particlesL Bonhomme, M C Mathieu, D Amdidouche, et al.
American Journal of Hospital Pharmacy|October 1, 1994
Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoinL Bonhomme, G Fredj, E Ecstein, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromaroneJ N Colin, R Farinotti, G Fredj, et al.
Transplantation Proceedings|December 1, 1991
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantationD Fries, P Rucay, D Samuel, et al.
Reviews of Infectious Diseases|November 1, 1986
Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapyJ P Stahl, J P Bru, G Fredj, et al.
Therapie|July 1, 1987
[Pharmacokinetics of cicletanine hydrochloride in patients with renal insufficiency]J M Lize, J L Durand, P Jungers, et al.
Transplantation Proceedings|June 1, 1993
Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipientD Azoulay, A Lemoine, J M Gries, et al.
Therapie|January 1, 1986
[Topical digestive drugs with a clay base. Influence on the absorption of cimetidine]G Fredj, R Farinotti, C Salvadori, et al.
Transplantation Proceedings|February 1, 1993
Limits of the MEGX test in the selection of liver grafts for transplantationR Adam, D Azoulay, I Astarcioglu, et al.
Hepatology (Baltimore, Md.)|December 1, 1994
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantationA Lemoine, D Azoulay, A Dennison, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|June 1, 1992
Intratumor treatment of C3H mouse mammary carcinoma with 5-fluorouracil adsorbed on activated charcoal particlesL Bonhomme, M C Mathieu, D Amdidouche, et al.
American Journal of Hospital Pharmacy|October 1, 1994
Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoinL Bonhomme, G Fredj, E Ecstein, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromaroneJ N Colin, R Farinotti, G Fredj, et al.
Transplantation Proceedings|December 1, 1991
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantationD Fries, P Rucay, D Samuel, et al.
Reviews of Infectious Diseases|November 1, 1986
Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapyJ P Stahl, J P Bru, G Fredj, et al.
Therapie|July 1, 1987
[Pharmacokinetics of cicletanine hydrochloride in patients with renal insufficiency]J M Lize, J L Durand, P Jungers, et al.
Transplantation Proceedings|June 1, 1993
Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipientD Azoulay, A Lemoine, J M Gries, et al.
Therapie|January 1, 1986
[Topical digestive drugs with a clay base. Influence on the absorption of cimetidine]G Fredj, R Farinotti, C Salvadori, et al.
Transplantation Proceedings|February 1, 1993
Limits of the MEGX test in the selection of liver grafts for transplantationR Adam, D Azoulay, I Astarcioglu, et al.
Hepatology (Baltimore, Md.)|December 1, 1994
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantationA Lemoine, D Azoulay, A Dennison, et al.
Pageof 5